224 related articles for article (PubMed ID: 26542246)
1. Body mass index is associated with higher Gleason score and biochemical recurrence risk following radical prostatectomy in Chinese men: a retrospective cohort study and meta-analysis.
Bai PD; Hu MB; Xu H; Zhu WH; Hu JM; Yang T; Jiang HW; Ding Q
World J Surg Oncol; 2015 Nov; 13():311. PubMed ID: 26542246
[TBL] [Abstract][Full Text] [Related]
2. Predictors of biochemical recurrence after radical prostatectomy in an Afro-Caribbean population in Guadeloupe (French West Indies).
Brureau L; Emeville E; Multigner L; Blanchet P
Prog Urol; 2018 Jun; 28(8-9):442-449. PubMed ID: 29789237
[TBL] [Abstract][Full Text] [Related]
3. Radical prostatectomy neutralizes obesity-driven risk of prostate cancer progression.
Schiffmann J; Salomon G; Tilki D; Budäus L; Karakiewicz PI; Leyh-Bannurah SR; Pompe RS; Haese A; Heinzer H; Huland H; Graefen M; Tennstedt P
Urol Oncol; 2017 May; 35(5):243-249. PubMed ID: 28161322
[TBL] [Abstract][Full Text] [Related]
4. Predictive factors associated with biochemical recurrence following radical prostatectomy for pathological T2 prostate cancer with negative surgical margins.
Aoun F; Albisinni S; Henriet B; Tombal B; Van Velthoven R; Roumeguère T
Scand J Urol; 2017 Feb; 51(1):20-26. PubMed ID: 27910728
[TBL] [Abstract][Full Text] [Related]
5. Abdominal obesity, hypertension, antihypertensive medication use and biochemical recurrence of prostate cancer after radical prostatectomy.
Ohwaki K; Endo F; Hattori K
Eur J Cancer; 2015 Mar; 51(5):604-9. PubMed ID: 25613441
[TBL] [Abstract][Full Text] [Related]
6. Patterns and predictors of early biochemical recurrence after radical prostatectomy and adjuvant radiation therapy in men with pT3N0 prostate cancer: implications for multimodal therapies.
Briganti A; Joniau S; Gandaglia G; Cozzarini C; Sun M; Tombal B; Haustermans K; Hinkelbein W; Shariat SF; Karakiewicz PI; Montorsi F; Van Poppel H; Wiegel T
Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):960-7. PubMed ID: 24351411
[TBL] [Abstract][Full Text] [Related]
7. Low body mass index is associated with adverse oncological outcomes following radical prostatectomy in Korean prostate cancer patients.
Koo KC; Yoon YE; Rha KH; Chung BH; Yang SC; Hong SJ
Int Urol Nephrol; 2014 Oct; 46(10):1935-40. PubMed ID: 24817520
[TBL] [Abstract][Full Text] [Related]
8. Obesity, risk of biochemical recurrence, and prostate-specific antigen doubling time after radical prostatectomy: results from the SEARCH database.
Freedland SJ; Branche BL; Howard LE; Hamilton RJ; Aronson WJ; Terris MK; Cooperberg MR; Amling CL; Kane CJ;
BJU Int; 2019 Jul; 124(1):69-75. PubMed ID: 30347135
[TBL] [Abstract][Full Text] [Related]
9. Tertiary Gleason pattern in radical prostatectomy specimens is associated with worse outcomes than the next higher Gleason score group in localized prostate cancer.
Özsoy M; D'Andrea D; Moschini M; Foerster B; Abufaraj M; Mathieu R; Briganti A; Karakiewicz PI; Roupret M; Seitz C; Czech AK; Susani M; Shariat SF
Urol Oncol; 2018 Apr; 36(4):158.e1-158.e6. PubMed ID: 29288003
[TBL] [Abstract][Full Text] [Related]
10. Assessing the Optimal Timing for Early Salvage Radiation Therapy in Patients with Prostate-specific Antigen Rise After Radical Prostatectomy.
Fossati N; Karnes RJ; Cozzarini C; Fiorino C; Gandaglia G; Joniau S; Boorjian SA; Goldner G; Hinkelbein W; Haustermans K; Tombal B; Shariat S; Karakiewicz PI; Montorsi F; Van Poppel H; Wiegel T; Briganti A
Eur Urol; 2016 Apr; 69(4):728-733. PubMed ID: 26497924
[TBL] [Abstract][Full Text] [Related]
11. Radical prostatectomy represents an effective treatment in patients with specimen-confined high pathological Gleason score prostate cancer.
Lughezzani G; Gallina A; Larcher A; Briganti A; Capitanio U; Suardi N; Lista G; Abrate A; Sangalli MN; Buffi N; Cestari A; Guazzoni G; Rigatti P; Montorsi F
BJU Int; 2013 May; 111(5):723-30. PubMed ID: 22487441
[TBL] [Abstract][Full Text] [Related]
12. Obesity, prostate-specific antigen nadir, and biochemical recurrence after radical prostatectomy: biology or technique? Results from the SEARCH database.
Ho T; Gerber L; Aronson WJ; Terris MK; Presti JC; Kane CJ; Amling CL; Freedland SJ
Eur Urol; 2012 Nov; 62(5):910-6. PubMed ID: 22921964
[TBL] [Abstract][Full Text] [Related]
13. Obesity and biochemical outcome following radical prostatectomy for organ confined disease with negative surgical margins.
Freedland SJ; Terris MK; Presti JC; Amling CL; Kane CJ; Trock B; Aronson WJ;
J Urol; 2004 Aug; 172(2):520-4. PubMed ID: 15247719
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for biochemical recurrence after robotic assisted radical prostatectomy: a single surgeon experience.
Tanimoto R; Fashola Y; Scotland KB; Calvaresi AE; Gomella LG; Trabulsi EJ; Lallas CD
BMC Urol; 2015 Apr; 15():27. PubMed ID: 25879548
[TBL] [Abstract][Full Text] [Related]
15. High preoperative neutrophil-lymphocyte ratio predicts biochemical recurrence in patients with localized prostate cancer after radical prostatectomy.
Lee H; Jeong SJ; Hong SK; Byun SS; Lee SE; Oh JJ
World J Urol; 2016 Jun; 34(6):821-7. PubMed ID: 26449784
[TBL] [Abstract][Full Text] [Related]
16. Preoperative sex steroids are significant predictors of early biochemical recurrence after radical prostatectomy.
Salonia A; Abdollah F; Capitanio U; Gallina A; Suardi N; Briganti A; Zanni G; Ferrari M; Castiglione F; Clementi MC; Rigatti P; Montorsi F
World J Urol; 2013 Apr; 31(2):275-80. PubMed ID: 22441310
[TBL] [Abstract][Full Text] [Related]
17. Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.
Ploussard G; Agamy MA; Alenda O; Allory Y; Mouracade P; Vordos D; Hoznek A; Abbou CC; de la Taille A; Salomon L
BJU Int; 2011 Jun; 107(11):1748-54. PubMed ID: 20883488
[TBL] [Abstract][Full Text] [Related]
18. Prostate-specific antigen level, stage or Gleason score: which is best for predicting outcomes after radical prostatectomy, and does it vary by the outcome being measured? Results from Shared Equal Access Regional Cancer Hospital database.
Mithal P; Howard LE; Aronson WJ; Kane CJ; Cooperberg MR; Terris MK; Amling CL; Freedland SJ
Int J Urol; 2015 Apr; 22(4):362-6. PubMed ID: 25728968
[TBL] [Abstract][Full Text] [Related]
19. Prostate-specific antigen density predicts favorable pathology and biochemical recurrence in patients with intermediate-risk prostate cancer.
Kang HW; Jung HD; Lee JY; Kwon JK; Jeh SU; Cho KS; Ham WS; Choi YD
Asian J Androl; 2016; 18(3):480-4. PubMed ID: 26178393
[TBL] [Abstract][Full Text] [Related]
20. BMI is associated with larger index tumors and worse outcome after radical prostatectomy.
Hayashi N; Matsushima M; Kido M; Naruoka T; Furuta A; Furuta N; Takahashi H; Egawa S
Prostate Cancer Prostatic Dis; 2014 Sep; 17(3):233-7. PubMed ID: 24841331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
